Agenus R&D day New York City
SPEAKER CLIPS
- Dr. Steve O'Day
The Revolution of Immuno-Oncology - Dhan Chand, PhD
NexGen CTLA-4, the AGEN1181 Advantage - Dr. Bradley J. Monk
Therapeutic Approaches in Cervical Cancer - What is needed - Dr. Manuel Hidalgo
Oncology: What Is Working and How Can We Improve?
A Cervical Cancer Overview - Anna Wijatyk, MD
Agenus Zalifrelimab and Bastilimab in Cervical Cancer - Cailin Joyce, PhD
Agenus VISION Platform – Innovation Continues - Walter Flamenbaum, MD
AgenTus - Allogeneic Cell Therapy Approach
